A4 Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
A4 Wealth Advisors's VRTX Position: Q3 2026 in Review
A4 Wealth Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 471 shares — an estimated $234K sold.
A4 Wealth Advisors first reported a position in VRTX in Q2 2026 and held it in 1 quarter. The position peaked at $234K in Q2 2026. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- A4 Wealth Advisors reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- A4 Wealth Advisors sold 471 Vertex Pharmaceuticals shares in Q3 2026, an estimated $234K.
- A4 Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- A4 Wealth Advisors's Vertex Pharmaceuticals position peaked at $234K in Q2 2026.
- 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on A4 Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.